Related references
Note: Only part of the references are listed.Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection
Pei-Chang Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink
Baiyu Yang et al.
CANCER EPIDEMIOLOGY (2016)
Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver Resection A Nationwide Cohort Study
Chun-Chieh Yeh et al.
ANNALS OF SURGERY (2015)
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
Jessica L. Petrick et al.
CANCER PREVENTION RESEARCH (2015)
Immunosenescence: Implications for response to infection and vaccination in older people
Alejandra Pera et al.
MATURITAS (2015)
Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
Ju-Young Shin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
Ju-Young Shin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Chemopreventive strategies in hepatocellular carcinoma
Siddharth Singh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy
Ching-Lung Lai et al.
HEPATOLOGY (2013)
A Comparison of the Cancer Incidence Rates between the National Cancer Registry and Insurance Claims Data in Korea
Hee Jung Seo et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
Sean F. Altekruse et al.
HEPATOLOGY (2012)
Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Vikrant V. Sahasrabuddhe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
Giovanni Sitia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2011)
Diclofenac Inhibits Tumor Necrosis Factor-α-Induced Nuclear Factor-κB Activation Causing Synergistic Hepatocyte Apoptosis
Lisa Fredriksson et al.
HEPATOLOGY (2011)
MECHANISMS OF DISEASE The Coagulopathy of Chronic Liver Disease
Armando Tripodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?
Mia Kumar et al.
CELL AND BIOSCIENCE (2011)
Platelets and the immune continuum
John W. Semple et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei-Hwei Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Using prescription claims data for drugs available over-the-counter (OTC)
Marianne Ulcickas Yood et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma
Michael A. Kern et al.
CANCER RESEARCH (2006)
Vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells
W Cui et al.
CLINICAL CANCER RESEARCH (2005)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Platelets mediate cytotoxic T lymphocyte-induced liver damage
M Iannacone et al.
NATURE MEDICINE (2005)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
